# The Correlation between Targeted Contrast-Enhanced Ultrasound Imaging and Tumor Neovascularization of Ovarian Cancer Xenografts in Nude Mice.

> **Reliability concern:** This paper was retracted on 2023-05-24. See notice: 10.1155/2023/9872503.

- **DOI:** [10.1155/2021/5553649](https://doi.org/10.1155/2021/5553649)
- **Rating:** Limited (2.0 out of 5)
- **Verdict:** A preclinical correlation study linking targeted ultrasound to ovarian cancer neovascularization, fatally undermined by an unidentified targeting antibody and pervasive text integrity issues.
- **Framework version:** v5.0
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-06-01
- **Evaluation page:** https://www.nabu.science/paper/10.1155%2F2021%2F5553649

## Strengths

- **Appropriate time-series paired imaging design** The study's use of seven time-point groups with paired ordinary versus targeted CEUS measurements within the same animals, correlated against histological endpoints, is a conceptually sound design for characterizing the temporal relationship between imaging parameters and neovascular density.
  - Dimension: methodological rigour
  - Location: Sections 2.1, 2.4
- **Dual converging imaging parameters measured** Both peak intensity and time to peak were measured and correlated with neovascular density, providing two independent imaging parameters that show consistent directional findings (positive and negative correlations, respectively) in weeks 2–4.
  - Dimension: contribution
  - Location: Abstract; Table 4; Figures 4, 6, 7
- **Appropriately hedged conclusions** The conclusions use qualifying language ('may provide a new method') rather than claiming clinical diagnostic utility directly, which is proportionate to the animal model evidence presented.
  - Dimension: reporting
  - Location: Section 6 (Conclusions)

## Limitations

- **Central targeting antibody never identified** The antibody used as the targeting agent — the central experimental variable — is referred to only as 'antibody' or 'anti-mouse monoclonal antibody' throughout the manuscript. No name, clone, catalog number, or supplier is provided, making the study irreproducible and the specificity claim unverifiable.
  - Dimension: methodological rigour
  - Location: Sections 2.1, 2.3, throughout manuscript
- **Pervasive off-topic text contamination** The Results and Discussion sections contain extensive passages on liposomes, nuclide prepositioning, circadian clock genes, chemotherapy, and apoptosis that are unrelated to the stated correlational study, raising concerns about manuscript assembly integrity.
  - Dimension: reporting
  - Location: Sections 3.1, 3.2, 4.1, 5.1, 5.2
- **Incomplete statistical and methodological reporting** The correlation analysis method (Pearson vs. Spearman) is not specified, no confidence intervals are reported, no power calculation justifies the n=7 per group design, and correlations for weeks 1, 5, 6, and 7 are not formally reported despite data being collected.
  - Dimension: methodological rigour
  - Location: Section 2.7; Abstract; Table 4

## Reliability checks

Concerns (4 of 4 checks).

- **Internal coherence:** Noted. The core correlational findings are internally consistent between abstract and results, but the manuscript contains extensive off-topic text passages (liposomes, nuclide prepositioning, circadian clock genes in Sections 4.1, 5.1, 5.2), a duplicated sentence between Sections 2.6 and 3.1, and therapeutic intervention language embedded in what is described as an observational study.
- **Research conduct:** Noted. Ethics approval is declared in general terms but no committee name or approval number is provided. No conflict of interest statement is present. The targeting antibody — the central experimental variable — is never identified by name, clone, or source, which is a critical omission for reproducibility.
- **Reference integrity:** Clean. All 21 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Concern
- **Summary:** This paper was retracted on 2023-05-24. See notice: 10.1155/2023/9872503.
- **Last checked:** 2026-10-17
